V3V fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Vita 34 AG engages in the collection, storage, and distribution of cells, tissues, blood, and blood components for the purpose of medical applications. It also engages in the development of products and drugs based on cells, tissues, and blood for medical application. The firm produces and manufactures viral vectors and CAR-T cells. It operates through the Vita 34 and PBKM segments. The company was founded by Eberhard F. Lampeter on April 28, 1997 and is headquartered in Leipzig, Germany.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
V3V does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company